Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000194303 | SCV000247030 | likely benign | not specified | 2015-07-20 | criteria provided, single submitter | clinical testing | |
Genomic Diagnostic Laboratory, |
RCV000258106 | SCV000328316 | benign | CHARGE syndrome | 2016-09-05 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000297563 | SCV000474376 | benign | Hypogonadotropic hypogonadism 5 with or without anosmia | 2018-01-12 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Ambry Genetics | RCV002314796 | SCV000848439 | benign | Inborn genetic diseases | 2016-08-27 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000258106 | SCV001010146 | benign | CHARGE syndrome | 2025-01-05 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000194303 | SCV001363293 | likely benign | not specified | 2019-03-04 | criteria provided, single submitter | clinical testing | Variant summary: The variant, CHD7 c.694C>A (p.Pro232Thr) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.0015 in 246218 control chromosomes, predominantly at a frequency of 0.012 within the South Asian subpopulation in the gnomAD database, including 1 homozygotes. The observed variant frequency within South Asian control individuals in the gnomAD database is approximately 9600 fold of the estimated maximal expected allele frequency for a pathogenic variant in CHD7 causing Congenital Heart Disease phenotype (1.3e-06), strongly suggesting that the variant is a benign polymorphism found primarily in populations of South Asian origin. The variant, c.694C>A has been reported in the literature in an individual affected with Tetralogy of Fallot (DAlessandro_2016). However, this report does not provide unequivocal conclusions about association of the variant with Congenital Heart Disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Four clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation and classified the variant as benign (X2) /likely benign (X2). Based on the evidence outlined above, the variant was classified as likely benign. |
Gene |
RCV001568745 | SCV001792670 | likely benign | not provided | 2021-03-18 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002500588 | SCV002803393 | benign | CHARGE syndrome; Hypogonadotropic hypogonadism 5 with or without anosmia | 2021-11-11 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001568745 | SCV004155837 | likely benign | not provided | 2023-04-01 | criteria provided, single submitter | clinical testing | CHD7: BP4, BS1 |
Prevention |
RCV003917743 | SCV004734462 | likely benign | CHD7-related disorder | 2019-05-16 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |